Ab Studio, Inc.

AbbVie Ventures

AbbVie, Inc.

ABLi Therapeutics, Inc.

Acelot, Inc.

Actinogen Medical Ltd.

AcuraStem

Aditum Bio

Aerska

Age1 Capital Management, LLC

Alithia Life Sciences Pty Ltd

Alix Ventures

ALSA Ventures

Alto Neuroscience Inc.

Arvakor AB

Aspen Neuroscience, Inc.

Astia Angels

Axoltis Pharma

Biogen

Biotechgate

Brenig Therapeutics

Brookline Capital Markets

Cantor Fitzgerald

CarMa Seed Investments

Catalent, Inc.

CITICS CLSA Capital Partners HK Ltd

ClavystBio

Click Therapeutics, Inc.

Cognitive Research Corporation

Cohesion Bureau

Compass Pathways

Convergence Partners

Cukierman & Co. Life Sciences

Damona Pharmaceuticals

DB Capital, LLC

DeBere Capital Partners

Dementia Discovery Fund, an SV Health Investors, LLC Fund

Eli Lilly and Company

Elmstead Partners LLC

EQT Life Sciences

F. Hoffmann-La Roche Ltd.

Ferghana Partners, Inc.

FieldLine Medical

Frazier Life Sciences

Gain Therapeutics, Inc.

H. Lundbeck A/S

IAG Capital Partners

Johnson & Johnson Innovation – JJDC, Inc.

Junson Capital

KeifeRx LLC

Ladenburg Thalmann & Co. Inc.

Lifespan Vision Ventures LLC

Lilly Asia Ventures

Lionheart Ventures

MC Services, Inc.

Merck Research Venture Fund

Mianus Capital LLC

Mizuho Securities Co., Ltd.

Nanocarry Therapeutics

NeuroDex

Neurvati Neurosciences, Inc.

Nexus Neurotech Ventures

NFX

Noble Capital Markets

Novartis Pharma AG

NRx Pharmaceuticals, Inc.

OCA Ventures

Oppenheimer & Co. Inc.

Otsuka Pharmaceutical Co., Ltd.

Palo Santo Fund

Pangea Botanica Ltd

PJT Partners

PMK-Ventures Pte. Ltd.

Pritzker Neuropsychiatric Disorders Research Consortium

PsyMed Ventures

Raya Therapeutic, Inc.

Receptive Bio, Inc.

Revalesio Corp

SEQENS

Silicon Valley Venture Growth Partners

Stream Biomedical, Inc.

Syndeio Biosciences

Teitur Trophics ApS

The Michael J. Fox Foundation for Parkinson's Research

Tiberend Strategic Advisors, Inc.

Tiziana Life Sciences

Treo Ventures

Two Bear Capital

Vandria SA

Wellington Management

WRF Capital

XEIA Venture Partners